Digital Out-of-hospital Management on Clinical Outcomes in Patients With Early Cardiogenic Shock

Recruiting N/A Interventional Study
Shock, Cardiogenic Shock
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
472 (estimated)
Sponsor
Renmin Hospital of Wuhan University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This clinical study was a multi-center, open-label, randomized controlled clinical trial. A total of 472 patients with early-stage cardiogenic shock were recruited and randomly divided into the experimental group and the control group, with 236 cases in each group. The HeartMed-HF digital out-of-hospital management was used to manage the patients in the experimental group, while the patients in th…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria 1. Age ≥ 18 years old; 2. The patient meets the diagnosis of early-stage cardiogenic shock, with SCAI stage A, B, or C during hospitalization; (1) SCAI stage A: Without signs of shock and meeting one of the following criteria: 1. Combined with extensive myocardial infarction, d…
Contacts

Chen jing, doctor

+86 13659840327

364580342@qq.com

CONTACT